Turbo Cancers on the Rise: Yale experts
Dr. Harvey Risch first reported in September 2023 that Clinicians at Yale Medical School were seeing some new cancer situations in adults as young as 25, with no family history of developing colorectal cancer, suddenly developing highly aggressive forms of the disease. So aggressive that between diagnosis and first treatment, the cancers have grown dramatically (1). This phenomenon has rapidly accelerated since the Pandemic.
These ‘turbo cancers’ do not conform to the normal behaviour of cancers, not only are they more aggressive, but there seem to be more genetic issues in these cancers.
Risch is Professor Emeritus of Epidemiology in the Department of Epidemiology and Public Health at the Yale School of Public Health and Yale School of Medicine.
In 2022 there was a report in Nature (2) from researchers at Harvard, amongst others referring to increases in young cancer, often described as Early Onset Cancer. Yale Researchers believe early onset cancer has gone turbo since the pandemic.
The CEO of the American Cancer Society described the report as “a call to arms.”
Doctor Jeremy Kortmansky and Doctor Mariya Rozenblit of Yale Medicine have observed that younger adults tend to have more aggressive-appearing cancers compared to older adults. And, so far, this difference is seen in various cancer types, including colorectal, gastric and oesophageal cancers and breast cancer. In fact, Yale Cancer Center has now developed an ‘Early Onset Cancer Program’ to focus on patients with these aggressive cancers and diagnosed between the ages of 18-49. They have done this in partnership with the Smilow Cancer Hospital, a leading comprehensive cancer center in Connecticut, affiliated with the Yale Cancer Center.
Dr Veda Giri is the newly appointed director in charge of Yale Cancer Center and Smillow’s Early Onset Program. When Dr. Giri surveyed Smilow’s patient records from the last two years, she discovered approximately 1,300 cases of early onset breast cancer, about 600 cases of early onset gastrointestinal cancers, and close to another thousand cases across other cancer types. These new figures came as a shock. “It’s a real issue that has to be prioritized,” Giri stated.
But it’s not just the aggression of these cancers; the genetic issues mean that drugs may not currently exist to treat these cancers. Then younger patients may also have young families, may have more financial issues and may worry more about fertility.
Turbo cancers and repurposed drugs: Dr William Makis and Dr John Campbell (YouTube 2025)
Studies and Case Reports of Cancer Following COVID-19 Vaccination?
Studies and case reports of various cancers following mRNA vaccination are helping experts understand the potential mechanisms that may be allowing these cancers to proliferate.In a 2023 Belgian study published in Frontiers Oncology, researchers presented the first case of malignant lymphoma in mice. Malignant lymphoma is a rare adverse event reported following mRNA COVID-19 vaccination.
Two days after receiving a booster dose of Pfizer’s COVID-19 vaccine, one of 14 mice suffered spontaneous death. Upon examination, the 14-week-old mouse had abnormally large organs and cancerous lymphoma in the liver, kidneys, spleen, heart, and lungs. Although showing direct causality is complex, the authors said their findings add to “previous clinical reports on malignant lymphoma development following novel mRNA COVID-19 vaccination.”
In a January 2023 paper in Medicina, researchers presented the case of a 66-year-old man who developed swollen lymph nodes 10 days after receiving his third dose of Pfizer. After further testing, the patient was diagnosed with stage 2 non-Hodgkin lymphoma (NHL). A literature review found eight additional cases of NHL that developed shortly after COVID-19 vaccination. Five lymphoma cases occurred after vaccination with Pfizer, one case after vaccination with AstraZeneca, one after the Johnson & Johnson shot, and one after vaccination with Moderna.
In an August 2022 Letter to the Editor in the Journal of the European Academy of Dermatology & Venereology, physicians described two patients diagnosed with diffuse large B-cell lymphoma that developed from swollen lymph nodes following vaccination with Pfizer’s COVID-19 vaccine.
The study’s authors found that diffuse large B-cell lymphoma “may rapidly grow” after vaccination with Pfizer’s COVID-19 vaccine and urged dermatologists to pay attention to swollen lymph nodes or masses near the injection site.
Swollen lymph nodes, or lymphadenopathy, is considered a common side effect of COVID-19 vaccination, more often observed following immunization with novel COVID-19 mRNA vaccines than other vaccines.
Lymphadenopathy is also an acknowledged “non-serious” adverse event of COVID-19 vaccination listed in the U.S. Food and Drug Administration’s (FDA) fact sheets for health care providers for both Moderna and Pfizer’s monovalent and bivalent vaccines. However, pharmaceutical companies and U.S. regulatory agencies have not assessed whether there’s a link between vaccine-related lymphadenopathy and cancer.
Urgent Need to Determine Underlying Causes of Turbo Cancers - Dr.William Makis
The exact mechanism giving rise to turbo cancers is unknown, and it’s unclear whether one or multiple mechanisms are responsible for these cancers, Dr. William Makis, an oncologist, cancer researcher, and nuclear medicine radiologist, told The Epoch Times in an email.
Dr. Makis provided the following several possible hypotheses for how mRNA COVID-19 vaccines could cause turbo cancers:
1. The current COVID-19 mRNA vaccines contain pseudouridine-modified mRNA, which attenuates or alters the activity of key proteins in the innate immune system, impairing cancer surveillance.
When activated, these key proteins, called toll-like receptors, can prevent tumors from forming and growing.
2. Vaccination alters T-cell signaling that induces profound impairment in type 1 interferon and cancer surveillance.
T-cells, a type of white blood cell, help the body’s immune system prevent cancer. Studies show that getting multiple shots increases the level of a particular antibody called IgG4, causing T-cell and interferon suppression, leading to an inability to keep cancer in check, Dr. Cole told The Epoch Times.
“Everyone gets atypical cells in their body every day, and having a surveillance system is important, but when the surveillance system is shut off, that allows these cells to go haywire. How long it stays suppressed, nobody knows, and these are the studies NIH (the National Institutes of Health) should have been doing,” said Dr. Cole.
3. The shift of the antibody IgG4 caused by repeated mRNA vaccination could create a tolerance for spike protein and impair the production of the antibodies IgG1 and IgG3 and cancer surveillance.
4. The spike protein produced by the body after COVID-19 mRNA vaccination may interfere with important tumor suppressor proteins—P53, BRCA 1, and two tumor suppressor genes.
5. The spike protein may interfere with DNA repair mechanisms.
6. The RNA from the COVID-19 vaccines may be reverse-transcribed and integrated into the human genome.
7. Pfizer and Moderna vials found to be contaminated with plasmid DNA containing SARS-CoV-2 spike protein may integrate into the human genome.
8. The presence of the simian virus 40 (SV40) in DNA discovered in Pfizer mRNA vaccine vials may lead to cancers—most notably, non-Hodgkin lymphoma and other lymphomas—as it did with SV40-contaminated polio vaccines.
9. mRNA-based vaccines may be triggering the release of oncogenes—oncomiRs or microRNAs, which can enhance or inhibit cancer development and participate in cancer biological processes, such as proliferation, invasion metastasis, angiogenesis, chemoresistance, and immune escape.
“I believe there is an urgent need to determine the underlying mechanisms of turbo cancers because, at this time, oncologists have nothing to offer patients who have developed a turbo cancer, and conventional cancer treatments offer minimal or no benefit,” Dr. Makis told The Epoch Times.
Mr. David Wiseman, a research scientist in pharmacy, pharmacology, and experimental pathology, told The Epoch Times in an email that neither Comirnaty—Pfizer’s fully approved version of its COVID-19 vaccine—nor Spikevax by Moderna has been evaluated for its potential to cause cancer.
On March 30, 2023, Mr. Wiseman and four other experts submitted a 27-page document to the National Academies Committee, an ad hoc committee tasked with reviewing relevant adverse events associated with COVID-19 vaccines.
Using the Vaccine Adverse Event Reporting System (VAERS)—a database co-managed by the U.S. Centers for Disease Control and Prevention (CDC) and FDA used for reporting vaccine adverse events—Mr. Wiseman and his coauthors found an excess of cancer signals for COVID-19 vaccines from Dec. 14, 2020, to July 24, 2023, compared to all other vaccines for all years beginning in 1990.
A safety signal indicates a condition may be linked to a vaccine but requires further analysis to confirm an association.
The findings complemented the CDC’s Proportional Reporting Ratio (PRR) analyses obtained through a Freedom of Information Act (FOIA) request that assessed adverse events reported from Dec. 14, 2020, to July 29, 2022.
A PRR compares reports of specific adverse events experienced after receiving Moderna or Pfizer’s COVID-19 vaccine to those following vaccination with any other vaccine or all non-COVID-19 vaccines. The CDC’s PRR report detected cancer signals for colon cancer, metastatic breast cancer, metastasis to the liver, bones, central nervous system, lymph nodes, breast masses, chronic lymphocytic leukemia, B-cell lymphoma, and follicular lymphoma.
Mr. Wiseman said it’s clear from the FOIA documents that the CDC is aware of cancer reports and isn’t being forthcoming.
“Government agencies knew there were going to be cancers with these shots, and they were trying to cover it up, but the data is trickling out,” Dr. Cole told The Epoch Times, referring to 490 pages of communications obtained from the NIH through a FOIA request.
The CDC is supposed to report on morbidity and mortality—and when a pathologist diagnoses anything, he or she uses a diagnosis code, and it goes to the federal basis that’s reported to federal tracking agencies, Dr. Cole explained.
“All these data subsets should be easy to find if agencies would report what they have,” he said. “We could see statistical changes in diagnosis in the past two and a half years since shots were rolled out. The question is, why are other governments around the world not doing this?”Case Reports of Turbo Cancer?
- Ivermectin 1.5mg/kg/day
- Fenbendazole 1500mg/day
Got the Jab? Take Action to Safeguard Your Health
If you developed symptoms you didn’t have before your shot, I would encourage you to seek out expert help. In light of the frequency of turbo cancers, postmenopausal women with breakthrough bleeding after their COVID jab would probably be wise to get evaluated to rule out endometrial cancer.At present, the Front Line COVID-19 Critical Care Alliance (FLCCC) seems to have one of the best treatment protocols for post-jab injuries. It’s called I-RECOVER protocol.
Sources and References
https://www.canceractive.com/article/yale-experts%20see%20rise%20in%20younger%20turbo%20cancer
2. Is early-onset cancer an emerging global epidemic? Current evidence and future implications; Ugai, T., Sasamoto, N., Lee, HY. et al. Nat Rev Clin Oncol 19, 656–673 (2022). https://doi.org/10.1038/s41571-022-00672-8
3. Professor sees vaccines causing cancer - https://www.canceractive.com/article/top-professor%20sees%20vaccines%20causing%20cancer
‼️ BANNED by YouTube, brought to you on @elonmusk's @X — SHARE‼️
— Eddie Hobbs 1215 (@RealEddieHobbs) October 21, 2024
I facilitated The People's Vaccine Inquiry for Ireland, where medical experts from around Ireland and UK dropped truth bombs about the pandemic response in this must-listen roundtable.
Dr Elizabeth Evans… pic.twitter.com/SPKxdTH5lf
Comments
Post a Comment